Antihyperglycemic drugs use and new-onset atrial fibrillation in elderly patients.

about

Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in Taiwan.

P2860

Q47103078-862E7C5A-88FD-4B92-97A1-CCDE0D557B07

P2860

Antihyperglycemic drugs use and new-onset atrial fibrillation in elderly patients.

Item

http://www.wikidata.org/entity/Q47927131

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Antihyperglycemic drugs use and new-onset atrial fibrillation in elderly patients.

@en

Antihyperglycemic drugs use and new-onset atrial fibrillation in elderly patients.

@nl

type

Item

label

Antihyperglycemic drugs use and new-onset atrial fibrillation in elderly patients.

@en

Antihyperglycemic drugs use and new-onset atrial fibrillation in elderly patients.

@nl

prefLabel

Antihyperglycemic drugs use and new-onset atrial fibrillation in elderly patients.

@en

Antihyperglycemic drugs use and new-onset atrial fibrillation in elderly patients.

@nl

P1476

Antihyperglycemic drugs use and new-onset atrial fibrillation in elderly patients

@en

P2093

Fu-Yu Yang

http://www.w3.org/2001/XMLSchema#string

Hung-Yi Chen

http://www.w3.org/2001/XMLSchema#string

Yi-Sheng Liou

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women's health study)

Diabetes mellitus, glycemic control, and risk of atrial fibrillation.

Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies.

Epidemiology and natural history of atrial fibrillation: clinical implications.

Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study.

Type 2 diabetes mellitus and risk of incident atrial fibrillation in women.

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial.

Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation.

P304

388-393

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ECI.12754

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gwo-Ping Jong

P577

2017-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28369870

http://www.w3.org/2001/XMLSchema#string

Antihyperglycemic drugs use and new-onset atrial fibrillation in elderly patients.

about

P2860

P2860

Antihyperglycemic drugs use and new-onset atrial fibrillation in elderly patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698